Click For Photo: https://i.dailymail.co.uk/1s/2018/10/09/16/4891418-0-image-a-96_1539098706745.jpg
Brexit could have a 'catastrophic' impact on UK cancer research and may trigger a staffing crisis, a new study has said.
Overseas staff contributed to nearly 80 per cent of papers published in the UK between 2007 and 2014, and collaboration with EU scientists is increasingly common.
Restrictions - Movement - Brexit - Healthcare - Research
Restrictions on free movement after Brexit could risk undermining healthcare based on the research, according to a review led by Queen's University in Belfast.
Germany has already overtaken Britain as the number one destination for cancer research funding in Europe, and experts fear the 'Brexit effect' will get worse.
Professor - Mark - Lawler - Centre - Cancer
Professor Mark Lawler, from the Centre for Cancer Research and Cell Biology at Queen's, said: 'Nearly 20 per cent of our research staff are non-UK born.
'The Brexit effect on our research reputation could be catastrophic.
Quality - Research - Cancer - Cancer - Care
'And given that high quality research underpins better cancer outcomes, we risk undermining the cancer care of our patients.'
UK researchers have attracted 4.8 billion Euros (£4.2bn) of European funding since 2014.
UK - Number - Destination - Research - Funding
In 2015, the UK was the number one destination for research funding in the EU but has since been overtaken by Germany – evidence of what academics say is the 'Brexit effect'.
In collaboration with King's College London and the University of Leeds, Irish researchers have produced new proof of the positive benefit that researchers from other EU countries have on cancer research in the UK.
Study - Cancer - Journal - Lancet - Oncology
The study, published in cancer journal The Lancet Oncology, showed the increasing number of scientific papers on cancer published by teams which include at least one member...
Wake Up To Breaking News!